Larris-Ify Home Care

“Written instructions to patient include: CFR(s): 484.60(e) Standard: Written information to the patient. The HHA must provide the patient and caregiver with a copy of written instructions outlining: This Standard is not met as evidenced by: Based on observation, record review, and interview, the agency failed to provide current written medication instructions for 1 of 1 skilled home visit observation with a nurse; and failed to provide a current written home exercise program for 1 of 1 skilled home visit observation with a physical therapist (PT). (Patient #3) Findings include: 2. During an observation on 09/24/2026 at 11:10 AM, PT 1 assisted Patient #3 with foot and leg exercises. The surveyor reviewed all admission and instruction packets in the home and found no written exercise instructions. During an interview on 09/24/2026 at 11:30 AM, PT 1 stated that he did not provide the family or patient with written exercise instructions. He explained that he verbally told the patient and family which exercises to perform and demonstrated those movements instead. During an interview on 09/24/2026 at 11:35 AM, the Administrator, who attended the home visit, confirmed the absence of written home exercise instructions in the home and stated that the PT held responsibility for providing them. 1. A review of Patient #3’s records during a home visit on 09/24/2026 at 11:10 AM showed that the Home Health Aide Plan of Care, Medication List, and Home Health Certification and Plan of Care in the home all reflected certification dates of 07/19/2026 to 09/16/2026, and were not current. During an interview on 09/24/2026 at 11:10 AM, the Administrator reviewed the documents in the admission packet and confirmed the information in the home was not current. She also confirmed the home lacked a PT Plan of Care and exercise instructions. 2. During an observation on 09/24/2026 at 11:10 AM, PT 1 assisted Patient #3 with foot and leg exercises. The surveyor reviewed all admission and instruction packets in the home and found no written exercise instructions. During an interview on 09/24/2026 at 11:30 AM, PT 1 stated that he did not provide the family or patient with written exercise instructions. He explained that he verbally told the patient and family which exercises to perform and demonstrated those movements instead. During an interview on 09/24/2026 at 11:35 AM, the Administrator, who attended the home visit, confirmed the absence of written home exercise instructions in the home and stated that the PT held responsibility for providing them.”

“Infection Prevention CFR(s): 484.70(a) Standard: Infection Prevention. The HHA must follow accepted standards of practice, including the use of standard precautions, to prevent the transmission of infections and communicable diseases. This Standard is not met as evidenced by: Based on observation, record review, and interview, the agency failed to remove gloves and perform hand hygiene during a bath, disinfect equipment and discard a cloth barrier after care for 2 of 3 home visit observations. (Patient #3) Findings include: 2. During an observation on 09/24/2026 at 11:10 AM, PT 1 assisted Patient #3 with foot and leg exercises. The surveyor reviewed all admission and instruction packets in the home and found no written exercise instructions. During an interview on 09/24/2026 at 11:30 AM, PT 1 stated that he did not provide the family or patient with written exercise instructions. He explained that he verbally told the patient and family which exercises to perform and demonstrated those movements instead. During an interview on 09/24/2026 at 11:35 AM, the Administrator, who attended the home visit, confirmed the absence of written home exercise instructions in the home and stated that the PT held responsibility for providing them. 410 IAC 17-12-1(m) 1. During an observation on 09/23/2026 at 11:10, RN 1 used vital‑sign equipment on Patient #3 and placed the equipment inside the nursing bag without cleaning the oximeter, blood pressure cuff, or thermometer. RN 1 removed the stethoscope from around her neck, listened to Patient #3, then placed it back around her neck without cleaning it before or after use. The Surveyor observed that RN 1’s nursing bag had one large compartment with a file folder used as a divider. RN 1 removed the dirty equipment (oximeter, blood pressure cuff, thermometer, and stethoscope) from the left side of the folder, cleaned the equipment, and then placed it back on the right side of file folder. RN 1 failed to maintain separation between clean and dirty areas in the nursing bag. RN 1 picked up the nursing bag and cloth barrier from the chair, sat down, draped the dirty barrier across her lap, and placed the nursing bag on top of the barrier, then placed note pad on top of nursing bag to write notes. RN 1 failed to prevent the dirty barrier from contacting herself or other items. The Administrator later picked up the dirty barrier, carried it under her left arm, and removed it from Patient #3’s home. RN 1 failed to properly dispose of dirty barrier after use. During an interview on 09/24/2026 at 2:26 PM, RN 1 stated that staff must clean equipment before placing it back in the bag and must clean stethoscope after removing it from the neck, before patient use, after patient use, and before placing it back around the neck. She stated the barrier should be placed in a bag after use and discarded. She confirmed that the nursing bag had one large compartment without separate clean and dirty sections. During an interview on 09/24/2026 at 11:20 AM, the Administrator stated that the nursing bag should have two separate areas—one for clean items and one for dirty—and that all equipment must be cleaned before being placed back in the nursing bag.”

“Interdisciplinary assessment of the patient CFR(s): 484.75(b)(1) Ongoing interdisciplinary assessment of the patient; This Element is not met as evidenced by: Based on observation, record review, and interviews, the agency failed to assess a wound and complete a medication review during 1 of 1 observed RN home visits (Patient #3). Findings include: Wound During an observation on 09/23/2026 at 11:45 AM, the Surveyor observed a nickel‑sized open area on the left lateral upper arm of Patient #3. The Surveyor pointed out the sore to RN 1, who failed to assess the open area. A review of Patient #3’s record did not show evidence of an open skin area, interventions for the open area, communication with other agency staff, or communication with the physician regarding the open area. During an interview on 09/23/2026 at 11:45 AM, RN 1 stated the area resulted from the patient #3 picking at her skin. She reported the patient had similar sores in the past and that staff were not measuring these open areas. During an interview on 09/23/2026 at 11:45 AM, a family member of Patient #3 stated the open area had been present for 2–3 months. The family had been using over‑the‑counter lotion or oil, but were currently out of both. They stated the physician instructed them to use Vaseline (ointment used to shields skin from harsh environmental elements) on area. During an interview on 09/24/2026 at 2:26 PM, RN 1 stated she did not return to assess the open area after the Surveyor pointed it out and did not complete additional documentation. She stated staff are required to measure wounds and then contact the physician for orders. RN 1 added that even if the physician is not concerned and does not issue new orders, the nurse must still assess and measure the wound. Medication Review 1. During an observation on 09/23/2026 at 11:10 AM, RN 1 did not review medications in the home with Patient #3’s family. During an interview on 09/23/2026 at 11:45 AM, RN 1 confirmed her visit with Patient #3 was complete and stated that medications are reviewed every other visit. 2. During the entrance conference on 09/22/2026 at 11:10 AM, the Alternate Administrator stated staff are required to review medications at every visit. 410 IAC 17-14-1(a)(1)(A)”

“Infection Prevention CFR(s): 484.70(a) Standard: Infection Prevention. The HHA must follow accepted standards of practice, including the use of standard precautions, to prevent the transmission of infections and communicable diseases. This Standard is not met as evidenced by: Based on record review, observation, and interview, the agency failed to ensure field staff followed appropriate infection control practices per agency policy while providing patient care in 1 of 3 home visits conducted. (Patient #7 ) Findings include: A policy titled “NURSING BAG TECHNIQUES” received from the agency indicated but was not limited to “When the visit is completed . . . Reusable equipment shall be cleaned using alcohol, antiseptic spray/towlette [sic] and/or soap and water as appropriate:” During a home visit at Patient 2’s home to observe PT 1, PT 1 entered and washed their hands using the patient’s bar soap at the patient’s bathroom sink, created a barrier appropriately, removed all supplies from the bag including a cloth gait belt, placed on one side of the barrier, began an assessment of Patient #2, placing all used equipment on the other side of the barrier. PT 1 placed the cloth gait belt around Patient #2, to assist with standing until Patient #2 indicated they needed to sit. PT 1 removed the gait belt and placed it with other dirty equipment. PT 1 used hand hygiene appropriately when doffing and donning gloves. After ensuring Patient #2 was in their chair comfortably, at 9:37, PT started to place items back into their bag including the gait belt. During an interview, PT 1 indicated they had used hand sanitizer on the equipment before placing the items back into his bag, and when queried about the cloth gait belt, PT 1 indicated they could not clean the belt before placing it in their bag, and that they were taught to clean everything before placing items in their bag. The Administrator indicated PT 1 knows to clean their equipment before placing the items in their bag. 410 IAC 17-12-1(m)”

“Retention of records CFR(s): 484.110(c)(1)(2) Standard: Retention of records. (1) Clinical records must be retained for 5 years after the discharge of the patient, unless state law stipulates a longer period of time. (2) The HHA’s policies must provide for retention of clinical records even if it discontinues operation. When an HHA discontinues operation, it must inform the state agency where clinical records will be maintained. This Standard is not met as evidenced by: Based on record review and interview the agency failed to evidence the retention of clinical records for patients for 9/11/21 through 11/8/21 in 1 of 2 discharged records (Patient #1), of 9 patient records reviewed. Findings include: 1. A policy titled “ Maintenance and Retention of Clinical Records” received from the administrator contained but was not limited to “To Maintain the integrity and security of clinical records while allowing access to the records … Clinical Records of adult patients are retained for a minimum of seven (7) years … or according to state law … All material shall be available for review by … Department of Health … during the retention period.“ 2. During the entrance conference on 11-29-23 at 9:56 AM the agency reported they had changed their electronic record system in 2023 and maintained closed files in a locked room in a locked filing cabinet. On 12-04-2023 at 9 AM a request to the Alternate Administrator was made for Patient # 1’s skilled nursing visit notes for December 2021, communication notes for December 2021, physician orders, resumption of care Oasis for January 2022, and communication notes, skilled nursing visits and physician orders for 2023. On 12-04-2023 at 1:24 PM the Alternate Administrator reported they were unable to provide all of the requested information in 2021 and 2022 as their electronic medical records provider reported there was no way to restore the information without corrupting the files. They reported it would take 30-60 days from this point forward to restore and access the past files and they might be able to retrieve some patients but the current issue was the migration of information from the old system to the new system. On 12-01-2023 at 1:45 this surveyor was not able to view the skilled nursing visits for Patient #1 from 11-10-2021 through and including 11-26-2021 utilizing the agency’s EMR system. Upon requesting skilled nursing visits for Patient #1, 11-10-2021 through and including 11-26-2021, the Alternative Administrator indicated they could not restore those visits without corrupting the files, and they would be destroyed.”

“A review of all current medications CFR(s): 484.55(c)(5) A review of all medications the patient is currently using in order to identify any potential adverse effects and drug reactions, including ineffective drug therapy, significant side effects, significant drug interactions, duplicate drug therapy, and noncompliance with drug therapy. This Element is not met as evidenced by: Based on record review, observation, and interview the agency failed to ensure the registered nurse completed thorough reviews of patients’ current medication, in 1 of 9 clinical records reviewed. (Registered Nurse 1, Administrative Personnel 5) (Patient #7) 1. A policy titled “MEDICATION MANAGEMENT-PATIENT INFORMATION” received from the agency indicated but was not limited to “PURPOSE: To facilitate continuity of care, treatment and/or services … by providing accurate and comprehensive information about patients’ medications … The Registered Nurse shall generate a list of the patient’s current medications and herbal remedies … documented in the initial assessment … the list of medications is incorporated into the plan of care … A copy of the completed medication list remains in the patient’s home chart … medications are reviewed and assessed during each skilled visit. Any changes … are conveyed to the ordering physician …. “ 2. The clinical record for Patient #7 contained a Plan of Care with a Start of Care date of 04-20-2023 and a certification period of 10-17-2023 to 12-15-2023 with diagnoses which included, but were not limited to: Type 2 Diabetes Mellitus (a condition that occurs due to a problem in the way the body regulates and uses sugar as a fuel) with diabetic neuropathy (a type of nerve damage that can occur with diabetes, most often affecting the legs and feet), hypertensive chronic kidney disease stage 2 (a condition where elevated blood pressures cause mild damage to the kidneys) Human immunodeficiency Virus (virus that attacks the body’s immune system, if not treated, can lead to AIDS (acquired immunodeficiency syndrome) there is currently no effective cure), long term use of insulin, long term use of aspirin. Skilled Nursing frequency was 1 time per week for 9 weeks for medication education and disease management. Medications listed on the Plan of Care: “JARDIANCE (an antidiabetic medication used to improve glucose control in people with type 2 diabetes) 10 MG ORAL TABLET … TAKE ONE TABLET BY MOUTH DAILY … LORSARTAN (used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes) 100 MG … TAKE ONE TABLET BY MOUTH DAILY … TRIUMEQ (for the treatment of HIV/AIDS, a combination of three different medications) [no dosage recorded] ORAL TABLET … TAKE ONE TABLET BY MOUTH DAILY … LEVOTHYROXINE (used to treat an underactive thyroid gland (hypothyroidism) replaces the missing thyroid hormone thyroxine) 50 MCG TAKE 1 TABLET BY MOUTH [sic] DAIY … ABACAVIR/DOLUTEGRAVIR/LAMIVUDINE (generic name for Triumeq) 600 MG-50MG-300 MG ORAL TABLET … TAKE 1 TABLET BY MOUTH DAILY … PRAVASTATIN (from a class of drugs called ‘statins’, may treat high cholesterol and triglyceride levels) 20 MG ORAL TABLET … TAKE ONE TABLET BY MOUTH DAILY … AMLODIPINE (used to treat high blood pressure and chest pain) 5 MG ORAL TABLET … TAKE ONE TABLET BY MOUTH DAILY … ASPIRIN (can treat pain, fever, headache, and inflammation. It can also reduce the risk of heart attack) 81 MG … TAKE ONE TABLET BY MOUTH DAILY … TRIAMTERENE-HYDROCHLOROTHIAZIDE (used to treat high blood pressure, works by helping your kidneys remove fluid and salt from your blood through urination) 75 MG-50 MG ORAL TABLET … TAKE ONE TABLET BY MOUTH DAILY … ALPHA LIPOIC ACID (an antioxidant that is made naturally in the body and also found in foods, used to break down carbohydrates and to make energy) [no dosage recorded] … TAKE ONE TABLET BY MOUTH DAILY … INSULIN GLARGINE (injection that treats diabetes by increasing insulin levels in the body, decreasing blood sugar levels) SOLOSTAR PEN 20 UNITS INJECT 47 UNITS UNDER THE SKIN EVERY MORNING SUBCUTANEOUS … DOXAZOSIN (can treat urinary problems caused by an enlarged prostate, can also treat high blood pressure when used alone or in combination with other medications) 1 MG ORAL TABLETS … TAKE TWO [sic] TABLET BY MOUTH EVERY BEDTIME …” The Plan of Care was signed 10-16-2023 by Administrative Personnel 5. The Plan of Care failed to evidence all medications the patient was actively taking, change in dosage of active medications, failed to identify duplications, and failed to ensure medications no longer in use were marked as discontinued. The clinical record for Patient #7 also contained a ‘MEDICATION PROFILE’ which listed the patient’s ‘active’ medications: “NORCO (combination medication is used to relieve moderate to severe pain, contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen)) 5MG-325MG ORAL TABLET TAKE 1 TABLET BY MOUTH EVERY 8-12 HOURS DAILY … PRAVASTATIN 20 MG ORAL TABLET, EXTENDED RELEASE TAKE 1 TABLET BY MOUTH DAILY … LEVOTHYROXINE 60 MCG TAKE 1 BY MOUTH DAILY … DOXAZOSIN 2 MG ORAL TABLET TAKE 1 TABLET BY MOUTH DAILY … LOSARTAN 100 MG ORAL TABLET BY MOUTH DAILY … ASPIRIN 81 MG TAKE 1 TABLET BY MOUTH DAILY … LEVOTHYROXINE [no dosage written for this second entry] TAKE 1 BY MOUTH DAILY … AMLODIPINE 5 MG TABLET BY MOUTH COMBINE WITH A 2.5 MG FOR A TOTAL OF 7.5 MG … LANTUS SOLOSTART PEN 100 UNITS/ML SUBCUTANEOUS SOLUTIONS INJECT 20 UNITS DAILY … AMLODIPINE 2.5 MG ORAL TABLET TAKE 1 TABLET BY MOUTH DAILY COMBINE WITH A 5MG TO EQ [sic] LY LY COMBINE WITH A 5MG …” The list also contained the following ‘active’ duplicated medications: “NIFEDIPINE (EQV-ADALAT CC) (antihypertensive drug and calcium channel blocker used to treat high blood pressure and chest pain) 60MG ORAL TABLET, EXTENDED RELEASE TAKE 1 TABLET BY MOUTH DAILY” (appeared twice), “TRIUMEQ ORAL TABLET 600-60-300 TAKE 1 TABLET BY MOUTH DAILY” and “ABACAVIR/DOLUTEGRAVIR/LAMIVUDINE 600 MG-50 MG- 300 MG ORAL TABLET TAKE 1 TABLET BY MOUTH DAILY” (these are the same medication). The Medication Profile failed to evidence all medications the patient was actively taking, change in dosage of active medications, failed to identify duplications, and failed to ensure medications no longer in use were marked as discontinued. During a home observation of HHA 1 with Patient #7, the agency folder in the home was reviewed and the patient was queried regarding its contents. Patient #7 indicated they had no medication list provided to them by the agency, nor a Plan of Care. When queried regarding current medications, the patient indicated a bottle of Gabapentin (used to relieve chronic neuropathic, or nerve pain) on the table was picked up from the pharmacy the previous day, prescribed as, “800 mg, 2 P.O. (by mouth) three times per day with meals”. The patient indicated had been taking this for more than 1 year to combat the pain in their legs. Patient #7 indicated had been a diabetic for 37 years and injected their own insulin every morning. Indicated was taking Lantus, and that this had recently been increased to 55 units every morning. Patient #7 brought more medication to the table and indicated these were all the medications currently being taken: Pravastatin 20 mg one by mouth daily, Tradjenta 5mg by mouth daily, Amlodipine 5mg by mouth daily, Losartan 100mg by mouth daily, Jardiance 25mg by mouth daily, Triumeq (abacavir 600mg/dolutegravir 50mg/lamivudine 300mg) one by mouth daily, Amlodipine Besylate 2.5mg by mouth daily, Levothyroxine 50mcg by mouth daily. The patient indicated they did not have Aspirin or Doxazosin. Indicated was no longer taking Nifedipine. During the Entrance Conference, when queried as to the process of drug regimen review, the Director of Nursing indicated medications were reviewed with every skilled nursing visit, the medication list is reviewed with patient, communication is made with the provider to ensure medications are accurate, and that clinicians should have the physical medications present for review, “go get the bottles”. In a telephone interview with Person 10, a Pharmacist with Entity 9, indicated the patient’s current regimen included the following, “Lantus Solostar 55 units every morning … Triumeq one daily … Amlodipine 7.5mg (2.5mg and 5mg) daily … Jardiance 25mg one daily … Gabapentin 800mg three times daily … Levothyroxine 50 mcg one daily … Tradjenta 5 mg one daily … Losartan 100mg one daily, Pravastatin 20mg ... [patient] has not picked this up, needs new prescription … no refills left … Triamterene/HCTZ 75/50mg … [patient] needs a new prescription, no refills left … test strips were last filled 12-29-2022 … lancets were last picked up 11 months ago, 01-12-2023 … [patient] has not picked up Alpha Lipoic Acid since 05-10-2023 …” In a telephone interview with Registered Nurse (RN) 1, when queried as to what is done in a home visit for Patient #7 who is on services for medication education, RN 1 indicated that Patient #7 is seen once a week and that the patient was visited the previous day. Indicated that during nursing visits the patient’s vital signs are recorded, lungs are listened to, and blood sugars are checked. When queried as to when medications are reviewed with the patient, RN 1 indicated the patient is asked every visit if there are any new medications. When queried as to when medications are reconciled, RN 1 indicated medications are reconciled at recertification. Indicated when visits are made, the patient has their medications on the kitchen table and these are reviewed. RN 1 indicated would also note when refills are needed and tell the patient to get new refills, when queried as to whether that needed to be done at yesterday’s visit RN 1 indicated they did not need to do that yesterday. When queried if RN 1 was aware the patient had a recent increase in their Lantus dosage, the nurse indicated was unaware. RN 1 indicated whenever there is a new medication or changes to medication, he/she calls Administrative Personnel 5 in the office who then calls the provider, or sometimes will call the provider themselves. When queried as to what the patient’s medication list is compared to during medication reconciliation, indicated he/she believes the agency provides a list from the provider’s office. RN 1 indicated was also unaware of the duplicate medications and discrepancies between the Plan of Care, the Medication Profile, and what was found in the home, and had nothing further to offer. When queried as to whether the Medication Profile on the agency’s Electronic Medical Records System was current and accurate, Administrative Personnel 5 indicated it was current and indicated this would be the same as what would be given to patients. When shown the medication list on Patient #7’s Plan of Care versus the Medication Profile, and noted each document contained conflicting information, Administrative Personnel 5 indicated was surprised by this finding and the discrepancies should not exist. When queried regarding the multiple discrepancies between Patient #7’s Plan of Care, Medication Profile, what was found in the Patient’s home, and what was confirmed with Person 10, a pharmacist with Entity 9, Administrative Personnel 5 and Administrator indicated there should be no duplicated medications. When informed Patient #7 had no visit schedule, no medication list, and no Plan of Care in the home, the Administrator and Alternate Administrator indicated these items should be in the patient’s home and updated after every recertification, and indicated they expected the RN would hand deliver these items to the patients home. 410 IAC 17-14-1(a)(1)(B)”

“Visit schedule CFR(s): 484.60(e)(1) Visit schedule, including frequency of visits by HHA personnel and personnel acting on behalf of the HHA. This Element is not met as evidenced by: Based on observation, record review, and interview the agency failed to ensure patients were provided with a written schedule detailing staff visit frequency, in 2 of 3 home visits observed. (Patients #2 and #7). Findings include: 1. During a home visit at Patient #2, a review of their agency folder failed to evidence a written schedule of staff. When queried how do they know when staff is going to be there, Patient #2 indicated the staff usually calls the day before to let them know, but we have a system worked out now and it’s all good. 2. On 12-01-2023 at 4:26 PM, the Administrator indicated the nurse should be putting a schedule in every patient’s folder. 3. During a home observation of HHA 1 with Patient #7, the agency folder in the home was reviewed and the patient was queried regarding its contents. The patient indicated there was not a ‘visit schedule’ from the agency and if there was, did not know where it might be. 4. On 12-01-2023 at 4:20 PM when informed Patient #7 had no visit schedule, no medication list, and no Plan of Care in the home, the Administrator and Alternate Administrator indicated these items should be in the patient’s home and updated after every recertification, and indicated they expected that the RN would hand deliver these items to the patients home.”

“Patient medication schedule/instructions CFR(s): 484.60(e)(2) Patient medication schedule/instructions, including: medication name, dosage and frequency and which medications will be administered by HHA personnel and personnel acting on behalf of the HHA. This Element is not met as evidenced by: Based on record review, observation, and interview the agency failed to ensure patients had written medication schedules/instructions for current medication regimen in the home, for 2 of 3 home visits observed. (Registered Nurse (RN) 1 and PT 1) (Patients #2, and #7) Findings include: 1. A policy titled “MEDICATION MANAGEMENT-PATIENT INFORMATION” indicated but was not limited to “PURPOSE: To facilitate continuity of care, treatment and/or services … by providing accurate and comprehensive information about patients’ medications … The Registered Nurse shall generate a list of the patient’s current medications and herbal remedies … documented in the initial assessment … the list of medications is incorporated into the plan of care … A copy of the completed medication list remains in the patient’s home chart … medications are reviewed and assessed during each skilled visit. “ 2. During a home visit at Patient #2, a review of their agency folder failed to evidence a written medication schedule with instructions on their current medication regimen. Patient #2 indicated they’ve been taking the same medication for a long time. When queried if staff ever teaches about the medications they’re taking, Patient #2 smiled and said they’ve been taking the same medication for a long time. 3. During a home observation of HHA 1 with Patient #7, the agency folder in the home was reviewed and the patient was queried regarding its contents. Patient #7 indicated they had no medication list/schedule provided to them by the agency, nor a Plan of Care. 4. During an interview, the Administrator indicated with recertification the nurse is to deliver the medication list to the patients.”

“Name/contact information of clinical manager CFR(s): 484.60(e)(5) Name and contact information of the HHA clinical manager. This Element is not met as evidenced by: Based on record review and interview the agency failed to ensure the patients have the correct information to contact the HHA’s clinical manager via phone or email in 2 of 3 home visits conducted. (Patients #2 and 6) Findings include: 1. A policy titled PATIENT CONCERNS/GRIEVANCES received from the agency indicated but was not limited to “To support and respect patients’ rights to have concerns/grievances about their care . . . heard . . . The information provided shall include the phone number, contact person . . . . “ 2. A review of a Governing Body minutes dated 05-04-2023 evidenced the Agency had appointed Employee 3, a Registered Nurse as the Director of Nursing/Clinical Supervisor in April of 2023 and the Administrator appointment was approved by The Indiana Department of Health on 04-01-2023. 3. During a home observation of Patient # 6, the Patient’s Agency folder contained a document listing the Agency’s phone number, and the space for Administrator and or Clinical Supervisor was blank. 4. When queried the alternate Administrator reported staff were to white out the name and put the new information about the Administrator and Clinical Supervisor in the patient’s information. 5. During a home observation with Patient #2, the Patient’s Agency folder contained a document listing the Agency’s phone number and listed Person 12 as the contact person. During an interview, Patient #2 indicated they had all of their numbers, but could not identify who the contact person would be at the agency. They indicated they would call PT 1 if anything was needed.”